UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Influence of Acute and Chronic Mineralocorticoid Excess on Endothelial Function in Healthy Men

Hypertension (Dallas, Tex. 1979), 2007-07, Vol.50 (1), p.82-88

2007

Link zum Volltext

Verfügbarkeit prüfen

Functional and Biochemical Analysis of Angiotensin II-Forming Pathways in the Human Heart

Circulation research, 1997-02, Vol.80 (2), p.219-227

1997

Link zum Volltext

Verfügbarkeit prüfen

Prolonged Oxygen Uptake Kinetics During Low-Intensity Exercise Are Related to Poor Prognosis in Patients With Mild-to-Moderate Congestive Heart Failure

Chest, 2003-08, Vol.124 (2), p.580-586

2003

Link zum Volltext

Verfügbarkeit prüfen

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design

The American heart journal, 2008-04, Vol.155 (4), p.609-614

2008

Link zum Volltext

Verfügbarkeit prüfen

Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure

Journal of the American College of Cardiology, 2003-07, Vol.42 (1), p.116-122

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial

JAMA : the journal of the American Medical Association, 2007-05, Vol.297 (18), p.1985

2007

Link zum Volltext

Verfügbarkeit prüfen

End-of-life preferences of elderly patients with chronic heart failure

European heart journal, 2012-03, Vol.33 (6), p.752-759

2012

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive Assessment of Cardiac Pumping Capacity During Exercise Predicts Prognosis in Patients with Congestive Heart Failure

Chest, 2002-10, Vol.122 (4), p.1333-1339

2002

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive Evaluation of Pulmonary Capillary Wedge Pressure by BP Response to the Valsalva Maneuver

Chest, 2002-07, Vol.122 (1), p.140-145

2002

Link zum Volltext

Verfügbarkeit prüfen

Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries

Journal of cardiovascular pharmacology, 1996-01, Vol.27 (1), p.147-153

1996

Link zum Volltext

Verfügbarkeit prüfen

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease

Transplantation, 1998-02, Vol.65 (4), p.538

1998

Link zum Volltext

Verfügbarkeit prüfen

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

Journal of cardiac failure, 2005-02, Vol.11 (1), p.12-20

2005

Link zum Volltext

Verfügbarkeit prüfen

Systemic endothelial dysfunction in adults with cyanotic congenital heart disease

Circulation (New York, N.Y.), 2005-08, Vol.112 (8), p.1106-1112

2005

Link zum Volltext

Verfügbarkeit prüfen

Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

Cardiovascular drugs and therapy, 1997, Vol.10 (6), p.717-725

1997

Link zum Volltext

Verfügbarkeit prüfen

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure

European journal of heart failure, 2001-08, Vol.3 (4), p.457-461

2001

Link zum Volltext

Verfügbarkeit prüfen

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Europace (London, England), 2013-01, Vol.15 (1), p.71-76

2013

Link zum Volltext

Verfügbarkeit prüfen

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study

European journal of heart failure, 2012-11, Vol.14 (11), p.1218-1229

2012

Link zum Volltext

Verfügbarkeit prüfen

Is Blood Pressure Response to the Valsalva Maneuver Related to Neurohormones, Exercise Capacity, and Clinical Findings in Heart Failure?

Chest, 1999-10, Vol.116 (4), p.861-867

1999

Link zum Volltext

Verfügbarkeit prüfen

B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction

European journal of heart failure, 2005-12, Vol.7 (7), p.1164-1167

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study

European heart journal, 2007-09, Vol.28 (17), p.2110-2117

2007

Link zum Volltext

Verfügbarkeit prüfen

Rationale and Perspective of Endothelin-1 Antagonism in Acute Heart Failure

Journal of cardiovascular pharmacology, 2001-11, Vol.38 Suppl 2, p.S53-S57

2001

Link zum Volltext

Verfügbarkeit prüfen

Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events

The Journal of pharmacology and experimental therapeutics, 1999-04, Vol.289 (1), p.565

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(110)

Sprache

Englisch
(110)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of Acute and Chronic Mineralocorticoid Excess on Endothelial Function in Healthy Men

Functional and Biochemical Analysis of Angiotensin II-Forming Pathways in the Human Heart

Prolonged Oxygen Uptake Kinetics During Low-Intensity Exercise Are Related to Poor Prognosis in Patients With Mild-to-Moderate Congestive Heart Failure

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial

End-of-life preferences of elderly patients with chronic heart failure

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

Noninvasive Assessment of Cardiac Pumping Capacity During Exercise Predicts Prognosis in Patients with Congestive Heart Failure

Noninvasive Evaluation of Pulmonary Capillary Wedge Pressure by BP Response to the Valsalva Maneuver

Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

Systemic endothelial dysfunction in adults with cyanotic congenital heart disease

Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study

2007 ESH-ESC Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

Is Blood Pressure Response to the Valsalva Maneuver Related to Neurohormones, Exercise Capacity, and Clinical Findings in Heart Failure?

B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction

Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study

Rationale and Perspective of Endothelin-1 Antagonism in Acute Heart Failure

Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events

Aktive Filter

Suchergebnisse filtern